tiprankstipranks
Akari Therapeutics (AKTX)
NASDAQ:AKTX

Compare Akari Therapeutics (AKTX) vs. Competitors

349 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Akari Therapeutics
$0.28
$4.33M
-0.56
-91.37%
1 Buy
1 Hold
0 Sell
Moderate Buy
NanoViricides
$1.13
$21.22M
-2.53
-8.22%
Moleculin Biotech
$2.62
$13.98M
-1.17
-85.67%
3 Buy
0 Hold
0 Sell
Strong Buy
Passage Bio
$9.89
$31.73M
-0.82
36.64%
5 Buy
0 Hold
0 Sell
Strong Buy
SAB Biotherapeutics
$3.75
$191.07M
5.44
217.80%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AKTX
Akari Therapeutics
3.83
-40.69
-91.40%
SONN
NNVC
NanoViricides
0.98
-0.21
-17.48%
MBRX
Moleculin Biotech
2.62
-18.11
-87.36%
PASG
Passage Bio
9.89
2.23
29.11%
SABS
SAB Biotherapeutics
3.75
2.36
169.78%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts